Desmopressin

Label

ClassVasopressin V2 analog

Typical routes in papersOral, nasal, SC/IV on labels

Half-life contextHours-range

EvidenceFDA-approved (diabetes insipidus, nocturia, some bleeding uses)

What it is

Desmopressin is a tweaked antidiuretic hormone. It tells the kidney to hold water and can raise some clotting factors.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

Medical benefits: less overnight urination, control of diabetes insipidus, selected bleeding disorders.
Athletes sometimes abuse ADH analogs to manipulate weight or look fuller. That is a hyponatremia trap.
This monograph exists so the archive names the real drug, not a “water peptide” myth.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Selective V2 receptor agonism increases aquaporin-2 water reabsorption; also releases vWF/FVIII at some doses.

Possible side effects / caveats

Low sodium (can be severe), water intoxication, seizures. Nasal forms have extra caution language in some uses.

Protocol ranges

Source tier	Amount	Frequency / duration	Notes
Label examples	Indication-specific	Oral / nasal / injectable	Do not copy a diabetes-insipidus dose into a research experiment

Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.